Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study

BACKGROUND: Community-acquired pneumonia (CAP) is a major cause of death worldwide and occurs with variable severity. There are few studies focused on the expression of soluble urokinase-type plasminogen activator receptor (suPAR) and syndecan-4 in patients with CAP. METHODS: A prospective, multi-ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Qiongzhen, Ning, Pu, Zheng, Yali, Shang, Ying, Zhou, Bing, Gao, Zhancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784729/
https://www.ncbi.nlm.nih.gov/pubmed/29368632
http://dx.doi.org/10.1186/s13054-018-1943-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784729/
https://www.ncbi.nlm.nih.gov/pubmed/29368632
http://dx.doi.org/10.1186/s13054-018-1943-y

Ejemplares similares